Surgical Sutures Market Worth US$6.65 billion by 2030 with 6.5% CAGR
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18374832
Browse in-depth TOC on 'Surgical Sutures Market'348 – Tables52 – Figures319 – Pages
By product, Suture thread dominates the surgical sutures market due to its essential role in wound closure across various surgical procedures. As the core component of any suturing system, it is integral to traditional open surgeries and minimally invasive techniques. The preeminence of suture thread can be attributed to its remarkable versatility, diverse material options, and continuous advancements in design and functionality. Innovations such as non-absorbable, absorbable, antibacterial-coated, and barbed suture threads have expanded their application spectrum across various surgical disciplines, including cardiovascular, orthopedic, gynecologic, and general surgery. Clinicians increasingly opt for threads characterized by high tensile strength, minimal tissue reactivity, and reliable absorption profiles—attributes that leading manufacturers consistently refine to meet the evolving demands of surgical practice.
By type, Multifilament sutures dominate the surgical sutures market due to their superior handling properties, reliable knot security, and broad application across various surgical specialties. These sutures are constructed from multiple braided or twisted filaments, which give them enhanced flexibility and tensile strength compared to their monofilament counterparts. This makes multifilament sutures particularly well-suited for surgical procedures that demand precise tissue closure, as they can adapt more readily to the contours of the tissue being sutured. The intricate design of multifilament sutures allows for better manipulation during surgical procedures, enabling surgeons to achieve a secure and stable closure. The improved knot-holding capability of these sutures is crucial in maintaining the integrity of the surgical site, reducing the risk of complications that can arise from loosening or failure. In high-pressure clinical environments, where time is often of the essence, the ease of handling that multifilament sutures provide can streamline surgical processes, ultimately contributing to shorter operation times and improved patient outcomes. Their versatility and effectiveness have made multifilament sutures a preferred choice among surgeons in numerous fields, including general surgery, orthopedics, and plastic surgery.
By geography, the surgical sutures market is characterized by five key regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America stands at the forefront of this market, bolstered by its advanced healthcare infrastructure, high surgical throughput, and the presence of leading industry players. The region features a robust network of hospitals, ambulatory surgical centers, and specialty clinics that engage in a wide array of complex surgical procedures—including cardiovascular, orthopedic, and general surgeries—all of which rely heavily on high-performance surgical sutures. Particularly, the US accounts for the largest market share due to its aging demographic, the prevalence of lifestyle-related chronic diseases, and an increasing demand for cosmetic and minimally invasive surgical interventions. Furthermore, North America is a hub for technological innovation, housing major corporations such as Ethicon and Medtronic, which consistently introduce cutting-edge suture materials and methodologies. This includes advancements in antimicrobial and absorbable sutures, which are crucial in improving surgical outcomes and patient safety.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18374832
The key players in the global surgical sutures market are Ethicon [Johnson & Johnson Services, Inc.] (US), Medtronic (Ireland), B. Braun SE (Germany), Advanced Medical Solutions Group Plc (UK), Healthium MedTech Limited (India), Boston Scientific Corporation (US) Zimmer Biomet Holdings, Inc. (US), Stryker (US), Smith+Nephew (UK), Conmed Corporation (US), Internacional Farmacéutica S.A. de C.V. (Mexico), Corza Medical (US), DemeTECH Corporation (US), Unisur Lifecare Pvt. Ltd (India), Assut Europe (Italy), RESORBA Medical GmbH (Germany), KATSAN Katgüt Sanayi ve Tic. A.S. (Turkey), Sutumed Corp. (US), Mellon Medical (Netherlands), Futura Surgicare Pvt. Ltd. (India), GMD Group (Turkey), Lotus Surgicals Pvt Ltd (India), BioSintex (Romania), Meril Life Sciences Pvt. Ltd. (India), and Aqmen Medtech (India).
Johnson & Johnson Services, Inc. [Ethicon] (US):
Ethicon, a subsidiary of Johnson & Johnson, is at the forefront of the surgical suture industry and is recognized for its advanced, high-quality products and comprehensive surgical solutions. The company excels in critical areas such as manufacturing infrastructure, extensive research and development capabilities, and a nuanced understanding of surgical requirements, enabling it to create cutting-edge wound closure innovations. Ethicon's suture portfolio is versatile, catering to various surgical disciplines, including orthopedic, gynecological, cardiovascular, and general surgery. This range encompasses absorbable and non-absorbable sutures, barbed sutures, antibacterial-coated options, and specialty sutures designed for specific applications. The company has made significant investments in technological innovation, especially in automated suture production and the development of bioengineered materials to promote optimal healing outcomes. Furthermore, Ethicon places a strong emphasis on surgeon education, offering global training programs aimed at enhancing surgical techniques and improving patient outcomes.
Medtronic (Ireland)
Medtronic stands as a prominent force in the surgical sutures sector, leveraging its extensive expertise in surgical solutions and wound closure technologies. The company's competencies are rooted in its innovative approach to clinical effectiveness, producing a diverse portfolio of sutures that effectively support both conventional and advanced surgical techniques. Renowned for high-performance offerings, Medtronic's sutures emphasize durability, biocompatibility, and ease of handling to cater to various subspecialties, including cardiovascular, gastrointestinal, and general surgery. The company maintains a robust commitment to research and development, focusing on enhancing product performance across a range of sutures, including absorbable, non-absorbable, and barbed varieties designed to meet the dynamic demands of surgical practice. One of Medtronic's significant advantages is its expansive global distribution network, coupled with strong engagement with surgeons, facilitating comprehensive training, education, and clinical support on a worldwide scale. Furthermore, the company strategically utilizes its diverse surgical portfolio to create integrated solutions, often bundling sutures with surgical staplers, energy devices, and ancillary instruments. This approach not only provides value-added offerings to healthcare facilities but also enhances surgical efficiency. With a strategic emphasis on expanding market access in emerging economies and addressing the increasing demand for minimally invasive surgical procedures, Medtronic remains a key and adaptive player within the surgical sutures arena.
For more information, Inquire Now!
Related Reports:
Wound Dressings Market
Advanced Wound Care Market
Minimally Invasive Surgical Instruments Market
Endoscopy Equipment Market
Electrosurgery Market
Get access to the latest updates on Surgical Sutures Companies and Surgical Sutures Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comVisit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/surgical-sutures-market-worth-us6-65-billion-by-2030-with-6-5-cagr–marketsandmarkets-302519491.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
2 hours ago
- The Star
India aghast at Trump's ‘dead' economy jibe, 25% tariffs
NEW DELHI: Shock, dismay and angst swept across India as businesses, policymakers and citizens digested US President Donald Trump's sharp remarks and a surprise 25% tariff rate earlier this week. While Indian government officials weighed a response and business groups tallied the cost of the trade barrier, the local social media flared up with users protesting Trump's comments and criticising Indian Prime Minister Narendra Modi for not speaking up. It started with Trump saying that India's trade barriers were the "most strenuous and obnoxious,' in a Truth Social post July 30. He added the US may also impose a penalty for New Delhi's purchase of Russian weapons and energy. Less than a day later, he ripped into India again for aligning with Russia, calling them "dead economies' in another post. With no imminent trade deal, the 25% tariffs kicked in as of Friday. India is hardly alone in facing Trump's trade wrath - and not the subject to the very highest rates - but the news left business and political leaders wondering how to cope with the fallout. "Overnight, the US-India trade equation shifted from tense to turbulent,' said Akshat Garg, assistant vice president at Choice Wealth, a Mumbai based financial services firm. The levies "feel less like structured policy and more like a blunt-force political message.' Complicating the narrative around the India trade deal - or the lack of it - was the US pact with its traditional rival Pakistan that came through on the same day. As the US released rates across the world on Aug. 1, India's relative disadvantage to competitor exporting countries became more apparent, dampening moods and stoking tempers further. "The biggest blow is that Pakistan and Bangladesh got a better rate than us,' V. Elangovan, managing director at SNQS Internationals, an apparel maker in the south Indian manufacturing hub of Tirupur, told Bloomberg News. "We were expecting something in the 15 to 20% range.' India's annoyance can be traced back in part to Trump declaring himself the peacemaker that helped broker a ceasefire in the armed conflict between India and Pakistan in May. The move was seen as an effort to upstage Modi and put the two South Asian neighbours on an equal footing, despite India's larger military and economy. The events of this week have cemented that impression further in the eyes of some Indian observers. When the tariff rate news first dropped in late Wednesday evening in India, Ashish Kanodia recalls being "very disturbed.' A director at Kanodia Global, a closely held exporter that gets over 40% of its revenue from the US selling home fabrics to toys, the entrepreneur already has two of its largest US customers seeking discounts to make up for the levy. "The next six months are going to be difficult for everyone,' Kanodia said, adding that profit margins will be squeezed. If the pain continues for "months and months,' he said he'll have to start cutting his workforce. The US is India's largest trading partner, with the two-way trade between them at an estimated US$129.2 billion in 2024. Compared with India's 25%, Bangladesh was subjected to a 20% tariff, Vietnam got a 20% levy and Indonesia and Pakistan each received 19% duties. "We know that we have got a deal that is worse than other countries,' said Sabyasachi Ray, executive director at The Gem and Jewelry Export Promotion Council. "We will take it up with the government.' Trump's actions mark a 180-degree turn for New Delhi's hopes of preferential treatment over regional peers. It was among the first to engage Washington in trade talks in February, confident of hammering out a deal sooner than others. Trump had called India's Prime Minister Narendra Modi "my friend' in a Feb 14 post on X and the bond between the two countries "special.' India is now weighing options to placate the White House, including boosting US imports, Bloomberg News reported citing people familiar with the matter, and many hope that the bilateral relationship and the tariff rate can still be improved. "It is a storm in the India-US relationship at this moment but I think there's a good chance that it will go away,' Vivek Mishra, deputy director of the Strategic Studies Programme at Delhi based Observer Researcher Foundation, told Bloomberg News. Indian business and trade groups are supporting the government's stance on the deal as the negotiations for a US-India trade deal continue. Jewelry businesses "are worried but they are not panicking' because they hope a more favourable deal can be worked out, said Ray of the gems export body. "The negotiation that should be happening should be a win-win, not a win-lose.' The abrupt announcement by Trump over social media when negotiations with India were ongoing "seems like a knee-jerk reaction,' according to Rohit Kumar, founding partner at public policy research firm The Quantum Hub. "This appears to be a negotiating tactic aimed at unresolved discussion points,' Kumar said. - Bloomberg
New Straits Times
3 hours ago
- New Straits Times
Tesla ordered to pay US$242mil over fatal Autopilot crash
NEW YORK: A Florida jury on Friday ordered Tesla to pay hundreds of millions of dollars to plaintiffs who blamed a deadly 2019 crash on the company's "Autopilot" driver assistance technology. The jury found Tesla's system partly responsible for a crash in Key Largo that killed Naibel Benavides Leon and injured her boyfriend, Dillon Angulo, according to attorney Darren Jeffrey Rousso, a partner at the law firm that represented Angulo and Leon's family. The plaintiffs had alleged that Autopilot was to blame when driver George McGee's Tesla careened into a Chevrolet sport utility vehicle, killing Leon and injuring Angulo. The jury awarded US$200 million in punitive damages, plus US$59 million in compensatory damages to Leon's family and US$70 million in damages to Angulo, according to court records. Since the jury assigned one-third of the blame to Tesla, the compensatory damages will be reduced, Rousso said, with the total impact of the jury award totalling US$242 million after these reductions. "Justice was done," Rousso said. "The jury heard all the evidence and came up with a fair and just verdict on behalf of our clients." Tesla will appeal the decision, according to its defence attorneys. "Today's verdict is wrong and only works to set back automotive safety and jeapordise Tesla's and the entire industry's efforts to develop and implement life-saving technology," Tesla said through its legal team. "The evidence has always shown that this driver was solely at fault because he was speeding, with his foot on the accelerator – which overrode Autopilot – as he rummaged for his dropped phone without his eyes on the road," Tesla said. "To be clear, no car in 2019, and none today, would have prevented this crash. This was never about Autopilot."--AFP
The Star
4 hours ago
- The Star
AI researchers are negotiating US$250mil pay packages. Just like NBA stars
SAN FRANCISCO: Over the summer, Matt Deitke got a phone call from Mark Zuckerberg, Meta's chief executive. Zuckerberg wanted Deitke, a 24-year-old artificial intelligence researcher who had recently helped found a startup, to join Meta's research effort dedicated to 'superintelligence,' a technology that could hypothetically exceed the human brain. The company promised him around US$125mil (RM534.7mil) in stock and cash over four years if he came aboard. The offer was not enough to lure Deitke, who wanted to stick with his startup, two people with knowledge of the talks said. He turned Zuckerberg down. So Zuckerberg personally met with Deitke. Then Meta returned with a revised offer of around US$250mil (RM1bil) over four years, with potentially up to US$100mil (RM427.8mil) of that to be paid in the first year, the people said. The compensation jump was so startling that Deitke asked his peers what to do. After many discussions, some of them urged him to take the deal – which he did. Silicon Valley's AI talent wars have become so frenzied – and so outlandish – that they increasingly resemble the stratospheric market for NBA stars. Young AI researchers are being recruited as if they are Steph Curry or LeBron James, with nine-figure compensation packages structured to be paid out over several years. To navigate the froth, many of the 20-somethings have turned to unofficial agents and entourages to strategise. And they are playing hardball with the companies to get top dollar, much as basketball players shop for the best deals from teams. The difference is that unlike NBA teams, deep-pocketed AI companies like Meta, OpenAI and Google have no salary caps. (Curry's most recent four-year contract with the Golden State Warriors was US$35mil/RM150mil less than Deitke's deal with Meta.) That has made the battles for AI talent even wilder. Over the past few weeks, recruiting AI free agents has become a spectacle on social media, much like the period before a trade deadline in sports. As Meta, Microsoft, Google and OpenAI have poached employees from one another, job announcements have been posted online with graphics resembling major sports trades, made by the online streaming outlet TBPN, which hosts an ESPN-like show about the tech and business world. 'BREAKING: Microsoft has poached over 20 staff members from DeepMind over the last six months,' read one recent TBPN post about Microsoft's hiring from Google's DeepMind lab. Jordi Hays, a co-host of TBPN, said that as tech and AI have gone mainstream, more people are following the recruitment fray 'the way our friends from college obsess over sports – the personalities, the players, the leagues.' On Wednesday, Zuckerberg said Meta planned to continue throwing money at AI talent 'because we have conviction that superintelligence is going to improve every aspect of what we do.' Superintelligent AI would not just improve the company's business, he said, but would also become a personal tool that 'has the potential to begin an exciting new era of individual empowerment.' A Meta spokesperson declined to comment. Deitke did not respond to a request for comment. The job market for AI researchers has long had parallels to professional sports. In 2012, after three academics at the University at Toronto published a research paper describing a seminal AI system that could recognise objects like flowers and cars, they auctioned themselves off to the highest corporate bidder – Google – for US$44mil (RM188.21mil). That kicked off a race for talent across the tech industry. By 2014, Peter Lee, Microsoft's head of research, was likening the market to that for up-and-coming pro football players, many of whom were making about US$1mil (RM4.28mil) a year. 'Last year, the cost of a top, world-class deep learning expert was about the same as a top NFL quarterback prospect,' Lee told Bloomberg BusinessWeek at the time, referring to a type of AI specialist. 'The cost of that talent is pretty remarkable.' The leverage that AI researchers have in negotiating job terms has only increased since OpenAI released the ChatGPT chatbot in 2022, setting off a race to lead the technology. They have been aided by scarcity: Only a small pool of people have the technical know-how and experience to work on advanced artificial intelligence systems. That's because AI is built differently from traditional software. These systems learn by analysing enormous amounts of digital data. Few researchers have experience with the most advanced systems, which require giant pools of computing power available to only a handful of companies. The result has been a fresh talent war, with compensation soaring into the hundreds of millions of dollars a year, from millions of dollars a year. In April, Zuckerberg – whose company was struggling to advance its AI research – dived in by sending personal messages to potential recruits, offering them larger and larger sums. His approach was similar to that of sports franchise owners, two Meta employees said. Even if the offers seemed absurd, if the new hires could help increase revenue by even half a percent – especially for a company that is closing in on a US$2 trillion (RM8.56 trillion) market capitalisation – it would be worth it, the people said. 'If I'm Zuck and I'm spending US$80bil (RM342.20bil) in one year on capital expenditures alone, is it worth kicking in another US$5bil (RM22.4bil) or more to acquire a truly world-class team to bring the company to the next level?' Hays said. 'The answer is obviously yes.' Meta's initial offers to engineers varied but hovered in the mid-tens of millions of dollars, three people familiar with the process said. The company also offered recruits something that was arguably more attractive than money: computing power. Some potential hires were told they would be allotted 30,000 graphical processing units, or GPUs, for their AI research, one of the people said. GPUs, which are powerful chips ideal for running the calculations that fuel AI, are highly coveted. Zuckerberg has hired with the help of the List, a document with the names of the top minds in AI, two people familiar with the effort said. Many on the List have three main qualifications: a doctorate in an AI-related field, experience at a top lab and contributions to AI research breakthroughs, one of the people said. The Wall Street Journal previously reported some details of the List. Some researchers on the List have created chat groups on Slack and Discord to discuss offers, two people in the groups said. When someone lands an offer, they can drop the details in the group chats and ask peers to weigh in. (AI is a tight-knit field where people often know one another.) They trade information about which companies to approach for another offer so they can build up their price, the people said. Working with friends can be just as important as the money. After a researcher joins a new lab, the first thing that person often does is try to recruit friends, two people familiar with the process said. The talent wars have started causing pain. OpenAI has changed its compensation structure to account for the shift in the market, employees at the company said, and is asking those approached by competitors to consult executives before immediately accepting offers. 'Are we countering? Yes,' Mark Chen, OpenAI's chief research officer, said at a company meeting this month, according to a recording reviewed by The New York Times. But he added that OpenAI had not matched Meta's offers because 'I personally think that in order to work here, you have to believe in the upside of OpenAI.' OpenAI declined to comment. (The Times has sued OpenAI and Microsoft, claiming copyright infringement in relation to news content related to AI systems. The two companies have denied the claims.) Not all of Meta's overtures have succeeded. The company has been rebuffed by some researchers, two people said, partly because Zuckerberg's vision for artificial intelligence was unclear compared to those at other companies. Still, the frenzy has allowed even little-known researchers like Deitke to chart their own destinies. Deitke, who recently dropped out of a computer science PhD program at the University of Washington, had moonlighted at a Seattle AI lab called the Allen Institute for Artificial Intelligence. There, he led the development of a project called Molmo, an AI chatbot that juggles images, sounds and text – the kind of system that Meta is trying to build. In November, Deitke and several Allen Institute colleagues founded Vercept, a startup that is trying to build AI agents, which can use other software on the Internet to autonomously perform tasks. With about 10 employees, Vercept has raised US$16.5mil (RM70.6mil) from investors such as former Google chief executive Eric Schmidt. Then came Deitke's back-and-forth with Zuckerberg. After Deitke accepted Meta's roughly US$250mil four-year offer, Vercept's CEO posted on social media, 'We look forward to joining Matt on his private island next year.' – © 2025 The New York Times Company This article originally appeared in The New York Times
